Isoflavone Profile and Biological Activity of Soy Bread

Journal of Agricultural and Food Chemistry

Volumn 51, Issue 26, 2003, Pages 7611-7616

  Zhang, Yu Chu ^a   Albrecht, Daniel ^a   Bomser, Joshua ^a   Schwartz, Steven J ^a   Vodovotz, Yael ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cancer cell proliferation; Isoflavones; Soy bread

Indexed keywords

DAIDZIN; GENISTIN; GLUCOSIDE; GLYCITEIN; ISOFLAVONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAD; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACTION; FOOD COMPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; SOYBEAN;

BREAD; CELL DIVISION; HUMANS; ISOFLAVONES; MALE; PROSTATIC NEOPLASMS; SOY FOODS; TUMOR CELLS, CULTURED;

GLYCINE MAX; TRITICUM AESTIVUM;

EID: 0347480133     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf034679c     Document Type: Article

References (51)

1. Anderson, J. J.; Smith, B. M.; Washnock, C. S. Cardiovascular and renal benefits of dry bean and soybean intake. Am. J. Clin. Nutr. 1999, 70, 464S-74S.
2. Anthony, M. S.; Clarkson, T. B.; Bullock, B. C.; Wagner, J. D. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 2524-31.
3. Hasler, C. M. The cardiovascular effects of soy products. J. Cardiovasc. Nurs. 2002, 16, 50-63; quiz 75-6.
4. Hermansen, K.; Sondergaard, M.; Hoie, L.; Carstensen, M.; Brock, B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 2001, 24, 228-33.
5. Nicolosi, R. J.; Wilson, T. A.; Lawton, C.; Handelman, G. J. Dietary effects on cardiovascular disease risk factors: beyond saturated fatty acids and cholesterol. J. Am. Coll. Nutr. 2001, 20, 421S-7S; discussion 40S-42S.
6. Scheiber, M. D.; Liu, J. H.; Subbiah, M. T.; Rebar, R. W.; Setchell, K. D. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 2001, 8, 384-92.
7. Cohen, L. A. Nutrition and prostate cancer: a review. Ann. N. Y. Acad. Sci. 2002, 963, 148-55.
8. Horn-Ross, P. L.; Barnes, S.; Lee, M.; Coward, L.; Mandel, J. E.; Koo, J.; John, E. M.; Smith, M. Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control 2000, 11, 289-98.
9. Adlercreutz, H. Phyto-oestrogens and cancer. Lancet Oncol. 2002, 3, 364-73.
10. Castle, E. P.; Thrasher, J. B. The role of soy phytoestrogens in prostate cancer. Urol. Clin. North Am. 2002, 29, 71-81, viii-ix.
11. Messina, M. J.; Persky, V.; Setchell, K. D.; Barnes, S. Soy intake and cancer Risk: A review of the in vitro and in vivo data. Nutr. Cancer 1994, 21, 113-31.
12. Murphy, P. A.; Song, T.; Buseman, G.; Barua, K.; Beecher, G. R.; Trainer, D.; Holden, J. Isoflavones in retail and institutional soy foods. J. Agric. Food Chem. 1999, 47, 2697-704.
13. Lachance, P. A. Nutriceuticals: Designer Food III Garlic, Soy, and Licorice; Food & Nutrition Press Inc: Trumbull, CT, 1997.
14. Klein, B. P.; Perry, A. K.; Adair, N. Incorporating soy proteins into baked products for use in clinical studies. J. Nutr. 1995, 125, 666S-74S.
15. Henkel, J. Health claims for soy protein, questions about other components. FDA Consum. 2000, 34, 13-5, 8-20.
16. Stein, K. FDA approves health claims labeling for foods containing soy protein. J. Am. Diet. Assoc. 2000, 100, 292-296.
17. Dalais, F. S.; Rice, G. E.; Wahlqvist, M. L.; Grehan, M.; Murkies, A. L. ; Medley, G.; Ayton, R.; Strauss, B. J. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998, 1, 124-9.
18. Knight, D. C.; Eden, J. A. A Review of the clinical effects of phytoestrogens. Obstet. Gynecol. 1996, 87, 897-904.
19. Makela, S.; Santti, R.; Salo, L.; McLachlan, J. A. Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ. Health Perspect. 1995, 103 Suppl. 7, 123-7.
20. Dwyer, J. T.; Goldin, B. R.; Saul, N.; Gualtieri, L.; Barakat, S.; Adlercreutz, H. Tofu and soy drinks contain phytoestrogens. J. Am. Diet. Assoc. 1994, 94, 739-43.
21. King, R. A.; Bignell, C. M. Concentrations of isoflavone phytoestrogens and their glucosides in Australian soya beans and soya foods. Aust. J. Nutr. Diet. 2000, 57, 70-8.
22. Barnes, S.; Kirk, M.; Coward, L. Isoflavones and their conjugates in soy foods - extraction conditions and analysis by HPLC mass-spectrometry. J. Agric. Food Chem. 1994, 42, 2466-74.
23. Coward, L.; Smith, M.; Kirk, M.; Barnes, S. Chemical modification of isoflavones in soyfoods during cooking and processing. Am. J. Clin. Nutr. 1998, 68, 1486S-91S.
24. Mahungu, S. M.; Diaz-Mercado, S.; Li, J.; Schwenk, M.; Singletary, K.; Faller, J. Stability of isoflavones during extrusion processing of corn/soy mixture. J. Agric. Food. Chem. 1999, 47, 279-84.
25. Grun, I. U.; Adhikari, K.; Li, C.; Li, Y.; Lin, B.; Zhang, J.; Fernando, L. N. Changes in the profile of genistein, daidzein, and their conjugates during thermal processing of tofu. J. Agric. Food Chem. 2001, 49, 2839-43.
26. Singletary, K.; Faller, J.; Li, J. Y.; Mahungu, S. Effect of extrusion on isoflavone content and antiproliferative bioactivity of soy/corn mixtures. J. Agric. Food Chem. 2000, 48, 3566-71.
27. Slavin, J. L.; Karr, S. C.; Hutchins, A. M.; Lampe, J. W. Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion. Am. J. Clin. Nutr. 1998, 68, 1492S-5S.
28. Izumi, T.; Piskula, M. K.; Osawa, S.; Obata, A.; Tobe, K.; Saito, M.; Kataoka, S.; Kubota, Y.; Kikuchi, M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 2000, 130, 1695-9.
29. Doerge, D. R.; Chang, H. C.; Churchwell, M. I.; Holder, C. L. Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab. Dispos. 2000, 28, 298-307.
30. Setchell, K. D.; Brown, N. M.; Desai, P.; Zimmer-Nechemias, L.; Wolfe, B. E.; Brashear, W. T.; Kirschner, A. S.; Cassidy, A.; Heubi, J. E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. 2001, 131, 1362S-75S.
31. Barnes, S. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 1995, 125, 777S-83S.
32. Chen, X.; Anderson, J. J. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr. Cancer 2001, 41, 165-71.
33. Barnes, S.; Peterson, T. G.; Coward, L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J. Cell. Biochem. Suppl. 1995, 22, 181-7.
34. Massey, L. K. Dietary animal and plant protein and human bone health: A whole foods approach. J. Nutr. 2003, 133, 862S-5S.
35. Nedeljkovi, A.; Radulovi, S.; Bjelogrli, S. Pleiotropic effect of genistein makes it a promising cancer protective compound. Arch. Oncol. 2001, 9, 171-174.
36. Onozawa, M.; Fukuda, K.; Ohtani, M.; Akaza, H.; Sugimura, T.; Wakabayashi, K. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Jpn. J. Clin. Oncol. 1998, 28, 360-363.
37. Suzuki, K.; Loike, H.; Matsui, H.; Ono, Y.; Hasumi, M.; Nakazato, H.; Okugi, H.; Sekine, Y.; Oki, K.; Ito, K.; Yamamoto, T.; Fukabori, Y.; Kurokawa, K.; Yamanaka, H. Genistein, a soy isoflavone, induces glutathione peroxidase in the huamn prostate cancer cell lines LNCaP and PC-3. Int. J. Cancer 2002, 99, 846-52.
38. Sathyamoorthy N.; Gilsdorf, J. S.; Want, T. T. Y. Differential effects of genistein on transforming growth factor beta-1 expression in normal and malignant mammary epithelial cells. Anticancer Res. 1998, 18, 2449-2454.
39. Wang, C.; Kurzer M. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nut. Cancer 1997, 28, 236-247.
40. Lemos, M. L. de. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann. Pharmacother. 2001, 35, 1118-1121.
41. Zill, H.; Bek, S.; Hofmann, T.; Huber, J.; Frank, O.; Lindenmeier, M.; Weigle, B.; Erbersdobler, H. F.; Scheidler, S.; Busch, A. E.; Faist, V. RAGE-mediated MAPK activation by food-derived AGE and non-AGE poducts. Biochem. Biophys. Res. Commun. 2003, 300, 311-315.
42. Hofmann, T.; Erbersdobler, H. F.; Kruse, I.; Faist, V. Molecular weight distribution of nonenzymatic browning products in Japanses soy sauce and studies on their effects on NADPH-cytochrome c-reductase and glutathione-S-transferase in intestinal cells. Int. Congr. Ser. 2002, 1245, 485-486.
43. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Iton, T.; Shibuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 26, 5592-95.
44. Zhang, R., Li, Y. and Wang, W. Enhancement of immune function in mice fed high does of soy daidzein. Nutr. Cancer 1997, 29, 24-8.
45. Yellayi, S.; Naaz, A.; Szewczykowski, M. A.; Sato, T.; Woods, J. A.; Chang, J.; Segre, M.; Allred, C. D.; Helferich, W. G.; Cooke, P. S. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 7616-7621.
46. Kim, H.; Peterson, T. G.; Barnes, S. Mechanisms of action of the soy isoflavone genistein: emerging role of its effects via transforming growth factor β signaling pathways. Am. J. Clin. Nutr. 1998, 68 (Suppl), 1418-25S.
47. Birt, D. F.; Hendrich, S.; Wang, W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 2001, 90, 157-77.
48. Kameoka, S.; Leavitt, P.; Chang, C.; Kuo, S.-M. Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids. Cancer Lett. 1991, 146, 161-167.
49. Wang, H. Z.; Zhang, Y.; Xie, L. P.; Yu, X. Y.; Zhang, R. Q. Effects of genistein and daidzein on the cell growth, cell cycle, and differentiation of human and murine melanoma cells. J. Nutr. Biochem. 2002, 13, 421-426.
50. 2/CIP1/WAF1 expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells. Biochem. Biophys. Res. Commun. 2001, 251, 291-295.
51. Appelt, L. L.; Reicks, M. M. Soy feeding induces phase II enzymes in rat tissue. Nutr. Cancer 1997, 28, 270-5.